Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Natural Remedies

Novartis Successfully Demonstrates Capabilities Of Cell-based Technology For Production Of A(H1N1) Vaccine
Novartis has successfully completed the production of the first batch of influenza A(H1N1) vaccine, weeks ahead of expectations. Cell-based manufacturing technology[1] allows vaccine production to be initiated once a pandemic virus strain is identified without the need to adapt the virus strain to grow in eggs, as with traditional vaccine technologies. This advance has cut weeks off the time required to begin vaccine production. This first batch of ten liters of wild type influenza A(H1N1) vaccine monobulk will be used for pre-clinical evaluation and testing and is also being considered for use in clinical trials. It demonstrates the value of the cell-based production approach, that is also being used by Novartis with reassortant influenza A(H1N1) seed.
generic viagra online
Swine Influenza Daily Update: 16 July 2009, Wales
The NPHS influenza surveillance scheme, which records reports of diagnoses of flufrom more than 300 GP practices across Wales, shows low but increasing levels of influenza activity across Wales. Further detail can be found on the NPHS website.
News of the day
Human Eye Inspires Advance In Computer Vision From Boston College Researchers
Inspired by the behavior of the human eye, Boston College computer scientists have developed a technique that lets computers see objects as fleeting as a butterfly or tropical fish with nearly double the accuracy and 10 times the speed of earlier methods.
Oncology

Law Firm Appointed To Boost Fight Against NHS Fraud

A new partnership between NHS Counter Fraud and law firm Capsticks will strengthen support to health bodies seeking to recover NHS funds lost to fraud. The innovative new scheme enables NHS bodies to make use of an accessible and cost effective civil recovery service in an area previously considered high risk. Capsticks" services under the new agreement include: - an advice line provided by a team of lawyers highly experienced in helping NHS bodies to respond to fraud - full litigation service where required - flexible funding options, including competitive rates agreed with NHS Counter Fraud, fixed fees and, where appropriate, "no-win-no-fee" arrangements. Dermid McCausland, Managing Director of NHS Counter Fraud, said: "I very much look forward to working with Capsticks and am sure this initiative will act as a strong deterrent to any potential fraudsters. Our aim is of course to prevent fraud from happening in the first place but we can now send a very clear message to those who do commit fraud: fraud against the NHS doesn"t pay and, wherever possible, we will be seeking financial recovery." Daniel Purcell, the Partner leading the work at Capsticks, said: "We are delighted to be working with NHS Counter Fraud to energise fraud response across the NHS. We look forward to bringing our experience and expertise in working with NHS bodies in countering fraud to this vitally important and high profile work." NHS Counter Fraud Service


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009